# Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine

> **NCT01380353** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Diclofenac epolamine patch

## Key facts

- **NCT ID:** NCT01380353
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-11-12
- **Final completion:** 2012-11-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380353, "Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01380353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*